Kelleher Financial Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $908K | Sell |
10,277
-172
| -2% | -$19.9K | 0.23% | 72 |
|
|
2025
Q4 | $1.1M | Sell |
10,449
-786
| -7% | -$73.8K | 0.25% | 61 |
|
|
2025
Q3 | $943K | Buy |
11,235
+928
| +9% | +$76.4K | 0.24% | 66 |
|
|
2025
Q2 | $816K | Buy |
10,307
+3,871
| +60% | +$308K | 0.28% | 53 |
|
|
2025
Q1 | $578K | Buy |
6,436
+379
| +6% | +$35.4K | 0.23% | 60 |
|
|
2024
Q4 | $603K | Buy |
6,057
+248
| +4% | +$25.6K | 0.23% | 59 |
|
|
2024
Q3 | $660K | Buy |
5,809
+100
| +2% | +$11.9K | 0.25% | 57 |
|
|
2024
Q2 | $707K | Sell |
5,709
-724
| -11% | -$93.3K | 0.29% | 53 |
|
|
2024
Q1 | $849K | Buy |
6,433
+78
| +1% | +$9.61K | 0.35% | 40 |
|
|
2023
Q4 | $693K | Buy |
6,355
+60
| +1% | +$6.23K | 0.33% | 44 |
|
|
2023
Q3 | $648K | Buy |
6,295
+1,001
| +19% | +$108K | 0.33% | 44 |
|
|
2023
Q2 | $611K | Buy |
5,294
+958
| +22% | +$109K | 0.35% | 50 |
|
|
2023
Q1 | $461K | Sell |
4,336
-907
| -17% | -$97.9K | 0.3% | 61 |
|
|
2022
Q4 | $582K | Sell |
5,243
-5,998
| -53% | -$613K | 0.44% | 47 |
|
|
2022
Q3 | $967K | Hold |
11,241
| – | – | 0.69% | 30 |
|
|
2022
Q2 | $10.2M | Buy |
11,241
+1
| +0% | +$89 | 4.61% | 7 |
|
|
2022
Q1 | $921K | Buy |
11,240
+1
| +0% | +$79 | 0.51% | 40 |
|
|
2021
Q4 | $852K | Buy |
11,239
+1
| +0% | +$80 | 0.45% | 44 |
|
|
2021
Q3 | $844K | Sell |
11,238
-99
| -0.9% | -$7.53K | 0.37% | 60 |
|
|
2021
Q2 | $882K | Sell |
11,337
-544
| -5% | -$40.5K | 0.5% | 39 |
|
|
2021
Q1 | $874K | Buy |
11,881
+1
| +0% | +$74 | 0.56% | 39 |
|
|
2020
Q4 | $926K | Sell |
11,880
-296
| -2% | -$22.6K | 0.7% | 31 |
|
|
2020
Q3 | $963K | Buy |
12,176
+1
| +0% | +$78 | 0.8% | 27 |
|
|
2020
Q2 | $898K | Buy |
12,175
+1
| +0% | +$75 | 0.86% | 26 |
|
|
2020
Q1 | $893K | Buy |
12,174
+297
| +3% | +$23.3K | 1.07% | 21 |
|
|
2019
Q4 | $1.03M | Buy |
11,877
+6,383
| +116% | +$524K | 1.04% | 22 |
|
|
2019
Q3 | $441K | Hold |
5,494
| – | – | 0.54% | 46 |
|
|
2019
Q2 | $439K | Buy |
+5,494
| New | +$421K | 0.54% | 47 |
|
|
2018
Q4 | $400K | Hold |
5,494
| – | – | 0.64% | 45 |
|
|
2018
Q3 | $371K | Hold |
5,494
| – | – | 0.48% | 53 |
|
|
2018
Q2 | $318K | Buy |
+5,494
| New | +$310K | 0.45% | 62 |
|
|
2018
Q1 | – | Sell |
-5,494
| Closed | -$294K | – | 90 |
|
|
2017
Q4 | $294K | Buy |
+5,494
| New | +$305K | 0.46% | 62 |
|
|
2017
Q1 | – | Sell |
-7,252
| Closed | -$407K | – | 115 |
|
|
2016
Q4 | $407K | Hold |
7,252
| – | – | 0.23% | 88 |
|
|
2016
Q3 | $431K | Sell |
7,252
-315
| -4% | -$18.4K | 0.24% | 81 |
|
|
2016
Q2 | $415K | Sell |
7,567
-1,004
| -12% | -$53.4K | 0.25% | 79 |
|
|
2016
Q1 | $432K | Buy |
8,571
+1,004
| +13% | +$49.2K | 0.24% | 88 |
|
|
2015
Q4 | $381K | Sell |
7,567
-1,048
| -12% | -$52.8K | 0.26% | 77 |
|
|
2015
Q3 | $405K | Buy |
8,615
+116
| +1% | +$6.16K | 0.27% | 73 |
|
|
2015
Q2 | $461K | Hold |
8,499
| – | – | 0.26% | 71 |
|
|
2015
Q1 | $466K | Hold |
8,499
| – | – | 0.26% | 69 |
|
|
2014
Q4 | $460K | Hold |
8,499
| – | – | 0.25% | 71 |
|
|
2014
Q3 | $470K | Sell |
8,499
-996
| -10% | -$55.9K | 0.25% | 71 |
|
|
2014
Q2 | $524K | Hold |
9,495
| – | – | 0.27% | 66 |
|
|
2014
Q1 | $514K | Sell |
9,495
-1,153
| -11% | -$59.7K | 0.28% | 65 |
|
|
2013
Q4 | $509K | Hold |
10,648
| – | – | 0.26% | 68 |
|
|
2013
Q3 | $484K | Sell |
10,648
-2,704
| -20% | -$123K | 0.28% | 61 |
|
|
2013
Q2 | $592K | Buy |
+13,352
| New | +$596K | 0.36% | 54 |
|
Other funds holding MRK
VCM
VPM
Kelleher Financial Advisors's MRK Position: Q1 2026 in Review
Kelleher Financial Advisors reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $19.9K and leaving 10,277 shares worth $908K. The position accounts for 0.23% of the portfolio, ranked #72.
Kelleher Financial Advisors first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $10.2M in Q2 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Kelleher Financial Advisors held 10,277 shares of Merck worth $908K as of Q1 2026.
- Kelleher Financial Advisors sold 172 Merck shares in Q1 2026, an estimated $19.9K.
- Merck made up 0.23% of Kelleher Financial Advisors's portfolio in Q1 2026, its #72 holding.
- Kelleher Financial Advisors first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
- Kelleher Financial Advisors's Merck position peaked at $10.2M in Q2 2022.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Kelleher Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.